Clinical Trials Search | Clareo Health

About Pricing FAQs Blog

Loading clinical trials...

Clareo Health

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Filters

Sort by

Status

Recruiting(Enrolling)

Not yet recruiting

Active, not recruiting

Enrolling by invitation(Enrolling)

Completed

Terminated

Phase

Early Phase 1

Phase 1

Phase 1/Phase 2

Phase 2

Phase 2/Phase 3

Phase 3

Phase 4

Not Applicable

Eligibility

Accepts healthy volunteers

Showing 1-1 of 1 trials

RECRUITINGPhase 2

A Study to Evaluate the Efficacy and Safety of ICP-248 in Subjects With Relapsed or Refractory Mantle Cell Lymphoma (APEX-06)

NCT07082686

This is a single-arm, multi-center, open-label, phase 2 study to evaluate the efficacy and safety of ICP-248 in subjects with relapsed or refractory mantle cell lymphoma.

Relapsed or Refractory Mantle Cell Lymphoma (MCL)

Beijing InnoCare Pharma Tech Co., Ltd.68 participantsStarted Aug 2025

Hefei, Anhui, China • Beijing, Beijing Municipality, China • Chengdu, Chengdu, China +26 more locations

Data from ClinicalTrials.govTerms